中文簡(jiǎn)介
本綜述提供了免疫學(xué)研究的最新信息。已發(fā)表的評(píng)論是由邀請(qǐng)的作者在他們的各個(gè)領(lǐng)域的領(lǐng)導(dǎo)者,重點(diǎn)是與醫(yī)學(xué)直接相關(guān)的主題。每一期《國(guó)際免疫學(xué)評(píng)論》包含4-6篇征求的文章,專門討論一個(gè)主題,由客座編輯編輯。本系列綜述適用于所有涉及自身免疫性疾病的免疫學(xué)家、分子生物學(xué)家、微生物學(xué)家和醫(yī)生。編輯的意圖是這本雜志提供最新的信息,填補(bǔ)目前存在的年度評(píng)論和原始研究文章之間的差距。周轉(zhuǎn)時(shí)間很短,以確保審查包含最新的數(shù)據(jù)。一個(gè)國(guó)際編輯委員會(huì)確保所提供的材料盡可能廣泛,包括投稿者的地理分布和所代表的興趣范圍。
英文簡(jiǎn)介
This review journal provides the most current information on research in immunology. The published reviews are written by invited authors who are leaders in their various fields and emphasis is given to subjects which have immediate relevance to medicine. Each issue of International Reviews of Immunology contains 4-6 solicited articles, is devoted to a single topic, and is edited by a guest editor. This review series is relevant to all immunologists, molecular biologists, microbiologists and physicians who are involved with autoimmune diseases. The editors' intent is that this journal provide the most recent information, filling the lag which presently exists between annual reviews and the original research articles. The turnaround time is short, in order to insure that the reviews contain the latest data. An international board of editors makes sure that the material presented is as broad as possible, both in terms of the geographic distribution of contributors and the range of interests represented.
近年期刊自引率趨勢(shì)圖
JCR分區(qū)
JCR分區(qū)等級(jí) | JCR所屬學(xué)科 | 分區(qū) | 影響因子 |
Q2 | IMMUNOLOGY | Q2 | 5.078 |
近年期刊影響因子趨勢(shì)圖
CiteScore數(shù)值
CiteScore | SJR | SNIP | 學(xué)科類別 | 分區(qū) | 排名 | 百分位 |
10.50 | 1.072 | 1.390 | 大類:Medicine 小類:Immunology and Allergy | Q1 | 31 / 200 |
84% |
大類:Medicine 小類:Immunology | Q1 | 37 / 213 |
82% |
相關(guān)醫(yī)學(xué)SCI期刊推薦
SCI期刊欄目
SCI期刊 工程技術(shù) 物理 生物 化學(xué) 醫(yī)學(xué) 農(nóng)林科學(xué) 數(shù)學(xué) 地學(xué)天文 地學(xué) 環(huán)境科學(xué)與生態(tài)學(xué) 綜合性期刊 管理科學(xué) 社會(huì)科學(xué)
期刊論文百科問(wèn)答
copyright © www.optiwork.cn, All Rights Reserved
搜論文知識(shí)網(wǎng) 冀ICP備15021333號(hào)-3